Inadequate erythropoietin response to anemia: definition and clinical relevance

Annals of Hematology

Volumn 68, Issue 5, 1994, Pages 215-223

  Barosi, G ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Erythropoiesis; Erythropoietin; Inadequate erythropoietin production

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; ERYTHROPOIESIS; FEEDBACK SYSTEM; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANEMIA; ERYTHROPOIESIS; ERYTHROPOIETIN; FEEDBACK; HOMEOSTASIS; HUMAN; RECOMBINANT PROTEINS;

EID: 0028359646     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/BF01737420     Document Type: Review

References (108)

1. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation
2. Recombinant human erythropoietin in the treatment of the anaemia of cancer
3. Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes
4. Erythropoietin response in anaemic patients with multiple myeloma and other lymphoid malignancies infiltrating the bone marrow
5. Blunted erythropoietin response to anemia in rheumatoid arthritis
6. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis
7. Classification of anaemia by means of ferrokinetic parameters
8. Control of erythropoietin production in man
9. Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia
10. Unreliability in immunoassays of erythropoietin: anomalous estimates with an assay kit
11. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy
12. Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production
13. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin
14. Erythrophagocytosis increases the expression of erythroid potentiating activity mRNA in human monocytemacrophages
15. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia
16. Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation
17. Studies on the mechanism of tumor necrosis factor alpha inhibition of hypoxia-induced erythropoietin production
18. Inadequate erythropoietin production in allogeneic bone marrow transplant patients
19. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes
20. The treatment of anaemia in myelodysplastic syndromes with recombinant human erythropoietin
21. Erythropoietin deficiency in the anemia of chronic disorders
22. Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units
23. Comparison of the erythropoietin response in children with aplastic anemia, transient erythroblastopenia, and iron deficiency
24. Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection
25. Reduced erythropoietin response to anaemia in elderly patients with normocytic anaemia
26. High-dose recombinant human erythropoietin administered intravenously for the treatment of anaemia in myelodysplastic syndromes
27. New tools for clinical evaluation of erythron function in man (annotation)
28. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase-I/II clinical trial
29. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure
30. Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia
31. An immunological cross-reactant of erythropoietin in serum which may invalidate EPO radioimmunoassay
32. Invalidity from nonparallelism in a radio-immunoassay for erythropoietin accounted for by human serum antibodies to rabbit IgG
33. Serum erythropoietin (ESF) titers in anemia
34. Erythropoietin titers in anemic, nonuremic patients
35. Erythropoietin
36. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a phase-I and -II clinical trial
37. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
38. B-lymphocytederived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF
39. Recombinant human erythropoietin for patients with AIDS treated with zidovudine
40. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias
41. Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin
42. Serum erythropoietin levels in the immediate kidney-posttransplant period
43. Zidovudine-induced blockade of the expression and function of the erythropoietin receptor
44. Some aspects of the regulation of erythropoietin gene expression
45. Changes in serum erythropoietin levels during allogeneic bone marrow transplantation
46. Treatment of myelodysplastic syndromes with recombinant human erythropoietin
47. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy
48. Improvement of anemia by intravenous injections of recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia
49. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia
50. Treatment of orthostatic hypotension with erythropoietin
51. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients
52. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
53. Quantitation of erythropoietin-producing cells in kidney of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration
54. Erythropoietin treatment in patients with myelodysplastic syndrome and anemia
55. Anaemia, iron-related measurements and erythropoietin levels in untreated patients with active leprosy
56. Cloning and expression of the human erythropoietin gene
57. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation
58. Erythropoietin treatment of anemia associated with multiple myeloma
59. Erythropoietin treatment of chronic anaemia of cancer
60. Oxygen content and erythropoietin levels in anemic cystic fibrosis patients
61. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
62. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies
63. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes
64. Decreased erythropoietin response in patients with the anemia of cancer
65. Impaired erythropoietin response to anemia after bone marrow transplantation
66. Phase I–II trial of erythropoietin in the treatment of cisplatin-associated anemia
67. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemia cells in vitro
68. Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin
69. Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status
70. Serum erythropoietin levels in hemodialysed patients after administration of recombinant human erythropoietin
71. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results
72. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis
73. Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows
74. Treatment of chemotherapy-induced anemias with recombinant human erythropoietin in cancer patients
75. Serum erythropoietin concentration in chronic renal failure. Relationship to degree of anaemia and excretory function
76. Recombinant human erythropoietin for treatment of myelodysplastic syndromes
77. Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin
78. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS-related complex. A doubleblind, placebo-controlled trial
79. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease
80. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures
81. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy
82. Erythropoietin therapy of myelodysplastic syndromes
83. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia
84. Recombinant human erythropoietin in patients with myelodysplastic syndromes
85. Increased plasma viscosity as a reason for inappropriate erythropoietin formation
86. Erythropoietin response in cancer patients receiving cisplatin
87. Serum immunoreactive erythropoietin in HIV-infected patients
88. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study
89. Iron kinetics
90. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes
91. Prediction of response to treatment with human recombinant erythropoietin in myelodysplastic syndromes
92. The International Standard for Recombinant DNA-derived Erythropoietin: collaborative study of four recombinant DNA-derived erythropoietins and two highly purified human urinary erythropoietins
93. Clinical significance of serum erythropoietin levels in patients with multiple myeloma
94. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis
95. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation
96. Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia
97. Serum erythropoietin titers in hematological malignancies and related diseases
98. Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia
99. Impaired erythropoietin production in mice treated with cyclosporin A
100. Serum levels of erythropoietin in anemias associated with chronic infection, malignancy and primary hemopoietic disease
101. Evaluation of erythropoietin levels in the anemia of thermal injury
102. Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome
103. Effect of human erythropoietin from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis
104. Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures
105. Anemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin
106. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis
107. Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment
108. Bone marrow erythropoiesis in the anemia of infection, inflammation and malignancy